Klebsiella pneumoniae is a multidrug resistant bacterium, which produces different enzymes that break down the structure of antibiotics.

肺炎克雷伯杆菌是一种多重耐药菌，它能产生多种分解抗生素的酶。

And let me tell you, they are not impressed by multidrug resistance.

让我告诉你， 他们对多重耐药性没有印象。

Because a few years back, one of the same scientists swabbed London hotel rooms—and found that 86 percent of the staph bacteria were multidrug resistant there.

因为几年前，同一位科学家对伦敦酒店房间进行了擦拭， 发现那里 86% 的葡萄球菌具有多重耐药性。

It's a multidrug resistant bacteria, and it can be treated with cephalosporins, aminoglycosides, fluoroquinolones, and carbapenems in case of beta-lactamase production; only with carbapenems in case of ESBL production; and with colistin, tigecycline or fosfomycin in case of carbapenemases production.

肺炎克雷伯杆菌也是一种多重耐药菌，如果产生β-内酰胺酶，可以用头孢菌素、氨基糖苷类、氟喹诺酮类以及碳青霉烯类药物治疗；如果产生ESBL，可以只应用碳青霉烯类进行治疗；如果产生碳青霉烯酶，则应用多粘菌素、替加环素或磷霉素进行治疗。